You Searched For "RP7214"

Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection

Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection

3 Dec 2020 4:28 AM GMT

Phase 1 Clinical Trial of RP7214 Set to Begin Early December 2020 Rhizen Pharmaceuticals S.A., an associate company of Alembic Pharmaceuticals Ltd.,...